Actively Recruiting
Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide
Led by Children's Hospital Los Angeles · Updated on 2026-04-30
16
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
C
Children's Hospital Los Angeles
Lead Sponsor
A
American Psychological Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are developing and initially testing a culturally adapted group intervention aimed at Black youth aged 12 to 17 who are at risk for suicide. The study focuses on evaluating whether this group approach is practical and well-received, as well as its early effects on reducing suicidal thoughts and behaviors. It also aims to improve protective factors like hope, positive ethnic identity, and support from family and peers. Participants will join a 10-week group intervention based on the Collaborative Assessment & Management of Suicidality (CAMS) model. The intervention is tailored to each participant's personal reasons for suicidal thoughts, helping them address these issues in a supportive group setting. Before and after the 10 weeks, participants will complete various assessments to measure changes related to suicidality and protective factors. Throughout the study, participants will complete assessments including the Suicide Status Form (SSF), Ethnic Identity Scale, Living Ladder Scale, and others, from before treatment until three months after finishing the group. These evaluations help researchers track the intervention's impact on suicidal thoughts, ethnic identity, hope, therapeutic relationships, and group cohesion. Participants and their caregivers will provide consent and assent to participate, and the total observation period spans about 22 to 23 weeks.
CONDITIONS
Brief Title
Bridge the Gap (BTG) - Black Youth Group
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 12 and 17 years old
- Identify as Black, African American, or of African descent
- Have current suicidal thoughts or have had suicidal thoughts within the past 30 days
- Have assent from the youth participant and consent from a caregiver or guardian to participate
You will not qualify if you...
- Have an active psychotic disorder or current psychosis symptoms
- Have no history of suicidal thoughts or attempts in the past 30 days
- Have cognitive deficits or medical conditions that prevent understanding study materials as assessed by the study team
- Caregivers, guardians, or the participant refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 weeks
Participants complete a 10-week group intervention based on the Collaborative Assessment & Management of Suicidality (CAMS) model, tailored to their individual suicide risk factors.
Weekly group sessions
Duration - Up to 12 weeks
Participants complete post-treatment assessments to evaluate outcomes for up to 3 months after the intervention ends.
1 to 2 visits during follow-up
Trial Site Locations
Total: 1 location
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
Actively Recruiting
Research Team
T
Tia Tyndal, PhD
A
Amy West, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here